MedPath

Tear Ferning Test for Dry Eye Diagnosis

Not Applicable
Recruiting
Conditions
Dry Eye Syndromes
Interventions
Other: with/without dry eye syndrome
Registration Number
NCT06364943
Lead Sponsor
Chung Shan Medical University
Brief Summary

Application of tear ferning test for clinical dry eye diagnosis

Detailed Description

Comparing dry eye patients' tear ferning structure with non-dry eye patients' to develop a protocol for easy and costless diagnosis in ophthalmology.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Aged between 20 and 65 years
  • For dry eye disease group:
  • Schirmer's test results between 5 - 10 mm
  • Tear Film Break Up Time less than 10 seconds
  • Ocular Surface Disease Index of more than 25
Exclusion Criteria
  • Those have diabetes, hypertension or other chronic diseases
  • No evident ocular diseases such as cornea disease, cataracts, vitreous degeneration, glaucoma, and retinopathy.
  • Belong to vulnerable groups(pregnancy woman, prisoner, ethical minorities, economic or educationally disadvantaged subjects, disabled individuals such as those at terminal stage of tumorigenesis, blindness, terminal ill individuals)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Non-Dry eye patientswith/without dry eye syndromeCollect clinical information and tear samples from patients without dry eye syndrome.
Primary Outcome Measures
NameTimeMethod
Ocular surface health evaluate3 minutes

To assess the health status with Lissamine green stain

Tear film breakup time20 seconds

to assess tear quality

Schirmer's test5 minutes

to assess tear secretion volume

Secondary Outcome Measures
NameTimeMethod
Intraocular pressure2 minutes

to determine the effects of intervention on intraocular pressure

Ocular surface disease index20 minutes

A questionnaire to assess the health status on ocular surface

A final score is calculated which ranges from 0 to 100 with scores 0 to 12 representing normal, 13 to 22 representing mild dry eye disease, 23 to 32 representing moderate dry eye disease, and greater than 33 representing severe dry eye disease.

Trial Locations

Locations (1)

Jen-Ai Hospital

🇨🇳

Taichung,, Taiwan

© Copyright 2025. All Rights Reserved by MedPath